The screening studies on the hypoglycemic action new amide derivatives of dicarboxylic acids
Keywords:malonic acid, oxalic acid, hypoglycemic action
The article have been devoted to screening tests hypoglycemic action of 43 new derivatives of malonic and oxalic acids. Studies carried out on rabbits with normal blood glucose. The studied compounds were administered at a dose of 1/20 LD50. Comparison drug was chosen bucarban a dose of 50 mg / kg. The relationship "structure - hypoglycemic effect" have been installed for new derivatives of dicarboxylic acids - amides of malonic and oxalic acids. A promising for further research is a compound under the laboratory code number 21, which is at a dose of 13,3 mg / kg shows a pronounced hypoglycemic effect on the level of the reference drug bucarban a dose of 50 mg / kg.
Доклінічні дослідження лікарських засобів: метод. рек. / за ред. О. В. Стефанова. – К. : Авіцена, 2001. – 528 с.
Программа статистического анализа. Режим электронного доступа www.analystsoft.com/ru
Рєзников О. Г. Загальні етичні принципи експериментів на тваринах / О. Г. Рєзников // Ендокринологія. – 2003. – Т. 8, № 1. – С. 142–145.
Adherence to Therapies in Patients with Type 2 Diabetes /L.-E. García-Pérez, M. Álvarez, T. Dilla, et. al. //Diabetes Ther.- 2013.- Vol. 4(2).-P. 175–194.
Chaparro M. New molecules in the treatment of inflammatory bowel disease / M. Chaparro, J.P. Gisbert //Gastroenterol Hepatol. – 2015. – Vol. 26. – Р.210-215.
Diabetes and related remedies in medieval Persian medicine /Mohammad M. Zarshenas А., Khademian S., et. al. //Indian J Endocrinol Metab. 2014.- Vol. 18(2): 142–149.
Huri H. Z. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia / H. Z. Huri, L. C. Ling //BMC Public Health. – 2013. -Vol.13.- P. 1192-1194.
Standards of Medical Care in Diabetes—2013 //American Diabetes Association. Diabetes Care.- 2013.- Vol. 36 (Suppl 1): S11–S66.
Vlassara H. AGE restriction in diabetes mellitus: a paradigm shift / H.Vlassara, Gary E. Striker // Nat Rev Endocrinol. 2011.- Vol. 24; 7(9). – P.526–539.
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).